NCT07222800 2026-01-30
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
Phase 3 Recruiting
Clinical Trials
20 trialsNCT07279077 2025-12-26
MODIFI-L
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Recruiting
NCT07152938 2025-09-15
AVR-CHEMO
Arab American University (Palestine)
Phase NA Completed
NCT04625803 2025-06-17
Neoadjuvant Therapy for Locally Advanced Colon Cancer
Zhejiang University
Phase 2 Completed
NCT06665087 2024-10-30
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
Fudan University
Phase 2 Not yet recruiting
NCT03794193 2022-05-04
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
Peking Union Medical College Hospital
Unknown
NCT02254941 2022-03-16
Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo
Unknown
NCT04495387 2021-04-27
Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy
University of Florence
Unknown
NCT00005944 2021-02-17
Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
UNICANCER
Phase 2 Terminated
NCT03985891 2020-12-17
JSFOL
Xiangya Hospital of Central South University
Phase 1/2 Recruiting
NCT01417494 2020-11-03
1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer
Federation Francophone de Cancerologie Digestive
Phase 2 Completed
NCT01471353 2020-07-23
SorCape
University of Florida
Phase 2 Completed
NCT01490996 2020-01-31
CUFOX
University of Leicester
Phase 1/2 Completed
NCT03062072 2017-04-07
ECHO
National Cancer Center, Korea
Unknown
NCT02363049 2017-02-23
CLIMAT
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT02997241 2016-12-20
CCTDRP
MyGenostics Inc., Beijing
Phase NA Unknown
NCT01322815 2016-08-15
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI
Georgetown University
Phase 2 Terminated
NCT00537901 2015-12-17
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT00873600 2015-03-19
Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer
Case Comprehensive Cancer Center
Withdrawn
NCT00006112 2011-04-26
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown